Preserved serotonin transporter binding in de novo Parkinson’s disease: negative correlation with the dopamine transporter
Karl Strecker, Osama Sabri(Klinik und Poliklinik für Nuklearmedizin), Florian Wegner(Leibniz University Hannover), Marianne Patt, Georg‐Alexander Becker(Leipzig University), Swen Hesse, Philipp Meyer(Leipzig University), Johannes Schwarz(Berlin Center for Epidemiology and Health Research), Donald Lobsien(Helios Klinikum Erfurt)
Cited by 80
Related Papers
Percutaneous Coronary Angioplasty Compared With Exercise Training in Patients With Stable Coronary Artery Disease
|Circulation|2004|774
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
|Alzheimer s & Dementia|2015|605
Four-repeat tauopathies
|Progress in Neurobiology|2019|217
Spontaneous white matter damage, cognitive decline and neuroinflammation in middle-aged hypertensive rats: an animal model of early-stage cerebral small vessel disease
|Acta Neuropathologica Communications|2014|215
Reduced α4β2*–Nicotinic Acetylcholine Receptor Binding and Its Relationship to Mild Cognitive and Depressive Symptoms in Parkinson Disease
|Archives of General Psychiatry|2009|156